CytoSorbents Announces HotSwap(TM) Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

Stock Information for NCS Multistage Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NCS Multistage Holdings Inc.

CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.